Early research (Phase 1)Not Yet RecruitingNCT07801612
What this trial is testing
A Phase I Study of HXN5003 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis
Who this might be right for
Health Adult SubjectsModerate-to-Severe Atopic Dermatitis
Helixon Biotechnology (Suzhou) Co., Ltd 68